Cargando…
SARS-CoV-2-Specific T Cell Immunity in HIV-Associated Kaposi Sarcoma Patients in Zambia
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) virus is the cause of coronavirus disease 2019 (COVID-19). It has caused millions of infections and deaths globally over a 2-year period. Some populations including those living with HIV and/or cancer are reported to be at a higher ri...
Autores principales: | Ngalamika, Owen, Mukasine, Marie Claire, Kamanzi, Patrick, Kawimbe, Musonda, Mujajati, Aaron, Tso, For Yue, Lidenge, Salum J., Mumba, Chibamba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352483/ https://www.ncbi.nlm.nih.gov/pubmed/35935575 http://dx.doi.org/10.1155/2022/2114285 |
Ejemplares similares
-
SARS-CoV-2-specific T cell and humoral immunity in individuals with and without HIV in an African population: a prospective cohort study
por: Ngalamika, Owen, et al.
Publicado: (2023) -
Viral and immunological markers of HIV-associated Kaposi sarcoma recurrence
por: Ngalamika, Owen, et al.
Publicado: (2021) -
Outcome markers of ART-treated HIV+ patients with early stage Kaposi’s sarcoma
por: Ngalamika, Owen, et al.
Publicado: (2020) -
Lack of CD8(+) T-cell co-localization with Kaposi’s sarcoma-associated herpesvirus infected cells in Kaposi’s sarcoma tumors
por: Lidenge, Salum J., et al.
Publicado: (2020) -
Antiretroviral Therapy for HIV-Associated Cutaneous Kaposi's Sarcoma: Clinical, HIV-Related, and Sociodemographic Predictors of Outcome
por: Ngalamika, Owen, et al.
Publicado: (2021)